chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: fatigued; dizzy; slight shortness of breath; face cheeks and tongue felt numb; face cheeks and tongue felt numb; tingling sensation; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 13Apr2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included positive Purified Protein Derivative (PPD) test and migraine with aura. The patient was allergic to bee stings. Concomitant medications included fluoxetine hydrochloride (PROZAC), taken for an unspecified indication from an unknown date. The patient previously took vicodin and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Apr2021 at 18:00, 6 hours after the first dose, the patient felt fatigued, dizzy, slight shortness of breath and face, cheeks and tongue felt numb. The event resulted in emergency room/department or urgent care. At the emergency room, the patient was told that it was tingling sensation and not numbness since he was able to move the tongue. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen. On 13Apr2021, the patient underwent COVID-19 test (nasal swab) in the emergency room and the result was negative. The clinical outcome of the events fatigued, dizzy, slight shortness of breath and numb/tingling at face, cheeks and tongue were resolved on unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, SARS-CoV-2 test
Clinical narrative: fatigued; dizzy; slight shortness of breath; face cheeks and tongue felt numb; face cheeks and tongue felt numb; tingling sensation; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 13Apr2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included positive Purified Protein Derivative (PPD) test and migraine with aura. The patient was allergic to bee stings. Concomitant medications included fluoxetine hydrochloride (PROZAC), taken for an unspecified indication from an unknown date. The patient previously took vicodin and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Apr2021 at 18:00, 6 hours after the first dose, the patient felt fatigued, dizzy, slight shortness of breath and face, cheeks and tongue felt numb. The event resulted in emergency room/department or urgent care. At the emergency room, the patient was told that it was tingling sensation and not numbness since he was able to move the tongue. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen. On 13Apr2021, the patient underwent COVID-19 test (nasal swab) in the emergency room and the result was negative. The clinical outcome of the events fatigued, dizzy, slight shortness of breath and numb/tingling at face, cheeks and tongue were resolved on unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Vaginal haemorrhage
Clinical narrative: Bloody nose; Randomly began bleeding vaginally, although it is not that time of the month.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the arm left on 13May2021 at 20:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included systemic scleroderma. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received no past drug or medication. On 15May2021 at 09:00, the patient randomly began bleeding vaginally, although it was not that time of the month and this evening the patient got a bloody nose. No therapeutic measures were taken as a result of the adverse event. The clinical outcome of the events randomly began bleeding vaginally, although it was not that time of the month and bloody nose were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Supraclavicular nodal swelling, left side; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13May2021 at 12:00 (at the age of 14-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medication included ibuprofen (ADVIL) for unspecified indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 15May2021 at 12:00, the patient experienced supraclavicular nodal swelling, left side. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event supraclavicular nodal swelling, left side was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 22Apr2021 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 13May2021 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis and allergy induced asthma. The patient had no known allergies. Concomitant medications included probiotics (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D) 50,000u 1x per week , 25xannax (MANUFACTURER UNKNOWN) on an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 00:00, 4 days after first dose, the patient had notice one swollen lymph node on the right side of her neck. It was still swollen for second dose. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph node was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Fatigue, Headache, Orthostatic hypotension
Clinical narrative: Was made worse by coughing; Head rushes; Sunday I was just really tried w/ headache/ I thenproceeded to have a headache for a full 2 weeks. Headache ranged from a 2-6 on pain scale; Fever of 100.4/ Fever remained b/w 101-102 for the next 12 hrs; Body aches; Fatigue.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 46-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: WAG 03657) via an unspecified route of administration in the right arm on 30Apr2021 at 14:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), sulfamethoxazole, trimethoprim (BACTRIM), gliclazide (CLARITIN) and fluticasone propionate (FLONASE); all from an unknown date for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: WAG 03657), via an unspecified route of administration in the right arm on 02Apr2021 at 16:30 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01May2021 at 07:00, following 2nd shot the next morning, the patient woke up with fever of 100.4 and body aches. Fever remained between 101-102 for the next 12 hours with body aches and fatigue. The patient took 2 naproxen (ALEVE) at 8pm which resolved fever and body aches within a couple of hours. On 02May2021, Sunday the patient was just really tried with headache. She then proceeded to had a headache for a full 2 weeks. Her headache ranged from a 2-6 on pain scale and was made worse while coughing or bending over. She had head rushes for the first week when ever going from sit to stand. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of fever and body aches which included treatment with 2 naproxen (ALEVE) at 8pm on 01May2021. No therapeutic measures were taken as a result of remaining events. The clinical outcome of fever of 100.4/ fever remained between 101-102 and body aches were recovered on 01May2021. The clinical outcome of coughing, fatigue, headache and head rushes were recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain assessment, Pyrexia
Clinical narrative: Was made worse by coughing; Head rushes; Sunday I was just really tried w/ headache/ I thenproceeded to have a headache for a full 2 weeks. Headache ranged from a 2-6 on pain scale; Fever of 100.4/ Fever remained b/w 101-102 for the next 12 hrs; Body aches; Fatigue.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 46-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: WAG 03657) via an unspecified route of administration in the right arm on 30Apr2021 at 14:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), sulfamethoxazole, trimethoprim (BACTRIM), gliclazide (CLARITIN) and fluticasone propionate (FLONASE); all from an unknown date for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: WAG 03657), via an unspecified route of administration in the right arm on 02Apr2021 at 16:30 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01May2021 at 07:00, following 2nd shot the next morning, the patient woke up with fever of 100.4 and body aches. Fever remained between 101-102 for the next 12 hours with body aches and fatigue. The patient took 2 naproxen (ALEVE) at 8pm which resolved fever and body aches within a couple of hours. On 02May2021, Sunday the patient was just really tried with headache. She then proceeded to had a headache for a full 2 weeks. Her headache ranged from a 2-6 on pain scale and was made worse while coughing or bending over. She had head rushes for the first week when ever going from sit to stand. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of fever and body aches which included treatment with 2 naproxen (ALEVE) at 8pm on 01May2021. No therapeutic measures were taken as a result of remaining events. The clinical outcome of fever of 100.4/ fever remained between 101-102 and body aches were recovered on 01May2021. The clinical outcome of coughing, fatigue, headache and head rushes were recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Inappropriate schedule of product administration
Clinical narrative: Patient received the second dose of vaccine on 17Mar2021; Have not had a period since receiving the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 03Mar2021 at 09:00 (at the age of 44-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 17Mar2021 at 09:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included escitalopram oxalate (LEXAPRO) for unknown indication from an unknown date and unknown if ongoing. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received the second dose outside the range of 19-42 days after the first dose and hence there was a medication error (inappropriate scheduling of vaccine administered). On 03Mar2021 at 09:00, the patient has not had a period since receiving the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event not had a period since receiving the vaccine was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Headache, Muscle spasms, Neck pain, Pain in extremity
Clinical narrative: "Black and blue'; Muscles spasms; "my neck ,legs, i feel pangs and my head"; "my neck ,legs, I feel pangs"; "my neck ,legs, I feel pangs"; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 27Apr2021 at 10:30 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS).Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 RNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 06Apr2021 at 10:30 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 03May2021, the patient reported black and blue and her neck, legs, she felt pangs and her head and muscles spasms. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events "black and blue" and "neck, legs, she felt pangs and her head" and muscles spasms were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: 4 months after receiving a Pfizer vaccine, developed without signifiant PMHx developed shingles.; This is a spontaneous report from a contactable healthcare professional, the patient. A 26-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an unspecified route of administration in the left arm on 04Jan2021 at 16:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 12:00, 4 months after receiving a Pfizer vaccine, the patient without significant past medical history (PMHx) developed shingles. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of shingles and included treatment with Valacyclovir 1g PO TID x 10days. The clinical outcome of the event shingles was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Small, itchy, pink bump at the second injection site; Small, itchy, pink bump at the second injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm right on 08May2021 at 11:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included Birth control tablets and multivitamin tablets from on an unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 17Apr2021 at 15:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 11:45, the patient experienced small, itchy, pink bump at the injection site that appeared seven days after. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event small, itchy, pink bump at the injection site was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Eye haemorrhage, Hyperaesthesia, Lymph node pain, Lymphadenopathy
Clinical narrative: I have hereditary lymphedema in my legs which became much worse/swelling/inner side of the knee where it was very swollen; I have hereditary lymphedema in my legs which became much worse; Having very sharp nerve pain; Stinging burning pain which is extremely sensitive to touch/Burning pain/ stinging burning pain was also behind her knee; Stinging burning pain which is extremely sensitive to touch/Burning pain; I also had a sore swollen lymph node; I also had a sore swollen lymph node; A broken blood vessel in my right eye; This is a spontaneous report from a contactable consumer via COVAES. This non-pregnant 64-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0171) via an unspecified route of administration in the left arm on 29Apr2021 (at 64-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, peripheral neuropathy, and hereditary lymphedema, all from unknown dates and unknown if ongoing. The patient had no allergies, had not received any other vaccines within 4 weeks prior to the COVID vaccine, and had not been diagnosed with COVID-19 prior to vaccination. Concomitant medications included gabapentin, baclofen, bupropion, and cetirizine, all from unknown dates for unknown indications. The patient previously received the first dose of BNT162B2 (lot number EW0151) in the left arm on 07Apr2021 (at the age of 64-years-old) for COVID-19 immunisation. The patient reported on 03May2021, she had hereditary lymphedema in her legs which became much worse within one week following the 2nd shot; further stating it had never been that bad before. The swelling was so severe that she believed it was pressing on nerves because she was having very sharp nerve pain and stinging burning pain which was extremely sensitive to touch. The stinging burning pain was also behind her knee and on the inner side of the knee where it is very swollen. She also had multiple sclerosis so at first she thought it was just from that because at the same time she had burning pain in her left side too and no lymphedema there. She reported that whenever she got sick with a virus it exacerbated her multiple sclerosis and burning pain was one of the symptoms. She also had a sore swollen lymph node under her left arm and a broken blood vessel in her right eye, which she had never had before, 2 days after the second shot. The patient reported that a doctor's office visit was required for the events, and that no treatment was received for the events. The clinical outcomes of the events were not recovered.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphoedema, Neuralgia, Pain
Clinical narrative: I have hereditary lymphedema in my legs which became much worse/swelling/inner side of the knee where it was very swollen; I have hereditary lymphedema in my legs which became much worse; Having very sharp nerve pain; Stinging burning pain which is extremely sensitive to touch/Burning pain/ stinging burning pain was also behind her knee; Stinging burning pain which is extremely sensitive to touch/Burning pain; I also had a sore swollen lymph node; I also had a sore swollen lymph node; A broken blood vessel in my right eye; This is a spontaneous report from a contactable consumer via COVAES. This non-pregnant 64-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0171) via an unspecified route of administration in the left arm on 29Apr2021 (at 64-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, peripheral neuropathy, and hereditary lymphedema, all from unknown dates and unknown if ongoing. The patient had no allergies, had not received any other vaccines within 4 weeks prior to the COVID vaccine, and had not been diagnosed with COVID-19 prior to vaccination. Concomitant medications included gabapentin, baclofen, bupropion, and cetirizine, all from unknown dates for unknown indications. The patient previously received the first dose of BNT162B2 (lot number EW0151) in the left arm on 07Apr2021 (at the age of 64-years-old) for COVID-19 immunisation. The patient reported on 03May2021, she had hereditary lymphedema in her legs which became much worse within one week following the 2nd shot; further stating it had never been that bad before. The swelling was so severe that she believed it was pressing on nerves because she was having very sharp nerve pain and stinging burning pain which was extremely sensitive to touch. The stinging burning pain was also behind her knee and on the inner side of the knee where it is very swollen. She also had multiple sclerosis so at first she thought it was just from that because at the same time she had burning pain in her left side too and no lymphedema there. She reported that whenever she got sick with a virus it exacerbated her multiple sclerosis and burning pain was one of the symptoms. She also had a sore swollen lymph node under her left arm and a broken blood vessel in her right eye, which she had never had before, 2 days after the second shot. The patient reported that a doctor's office visit was required for the events, and that no treatment was received for the events. The clinical outcomes of the events were not recovered.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vomiting
Clinical narrative: Puking; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0179) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0175) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient had experienced puking and chills on an unknown date. The clinical outcome of the events puking and chills was unknown at the time of report.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Muscle spasms, Neck pain, Pain
Clinical narrative: I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 21Apr2021 at 14:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient was not reported. The patient had no known allergies to food, medicine or other products. The patient did not receive any other medications within two weeks prior to vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 14:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 the patient experienced pain so bad on left side, cramp left leg twice at night, left hand, back, chest, neck were suffering from pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events pain so bad on left side, cramp left leg twice at night, left hand, back, chest, neck were suffering from pain was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; I AM IN PAIN SO BAD ON LEFT SIDE, CRAMP LEFT LEG TWICE AT NIGHT, LEFT HAND, BACK, CHEST, NECK ARE SUFFER PAIN; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 21Apr2021 at 14:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient was not reported. The patient had no known allergies to food, medicine or other products. The patient did not receive any other medications within two weeks prior to vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 14:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 the patient experienced pain so bad on left side, cramp left leg twice at night, left hand, back, chest, neck were suffering from pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events pain so bad on left side, cramp left leg twice at night, left hand, back, chest, neck were suffering from pain was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Diarrhea, occurred the day after receiving 1st vaccine, in the morning. Also had it again after eating dinner two or three times.; Then proceeded to vomit once; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on 14May2021 at 12:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had no known allergies. The patient did not receive concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15May2021 at 08:00 the patient experienced diarrhea, occurred the day after receiving 1st vaccine, in the morning.  Also had it again after eating dinner two or three times. Then vomited once. Do not know how long it was last. Patient had a hope it will resolve itself tomorrow. Elisa is 12 years old had received vaccine within a few days of vaccinations opening to her age group. Therapeutic measures were not taken as a result of the reported event(s). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event diarrhea, occurred the day after receiving 1st vaccine, in the morning and then vomit once was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Extreme dizziness; Nausea; Vomiting lasting for multiple days and still has not gone away.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 11May2021 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not allergic to any medications, food, or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 20Apr2021 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14May2021, at 12:00,  the patient had extreme dizziness, nausea and vomiting lasting for multiple days and still has not gone away. It was reported that the patient would try to see a physician the following day. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events dizziness, nausea and vomiting were unknown at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Muscle twitching
Clinical narrative: Lymph nodes still swollen to this day,; twitching of leg, upper lip; headaches after consumption of alchocol that were not bad at all prior to injection; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0172) via an unspecified route of administration in the left arm on 21Apr2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Apr2021, the patient experienced lymph nodes still swollen to this day, twitching of leg, upper lip and headaches after consumption of alcohol that were not bad at all prior to injection. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event lymph nodes still swollen to this day, twitching of leg, upper lip and headaches after consumption of alcohol that were not bad at all prior to injection were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected. .
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Headache, Mood swings, Nasal congestion
Clinical narrative: Pain in arm; tiredness; Headaches; Congestion; Mood swings; Extreme fatigue; Upset stomach; Running nose; Sore throat; Fever; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09May2021 at 11:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, allergy to nuts and nickel. Concomitant medications included zolpidem tartrate (AMBIEN), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and valaciclovir hydrochloride (VALTREX), all for unknown indication and from unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13May2021, the patient experienced pain in arm and quick onset tiredness which lasted for few days. On day 4, the patient experienced running nose, sore throat, fever, body aches and from day 5-7, patient experienced headaches, body aches, congestion, fever, sore throat, mood swings, extreme fatigue, upset stomach. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events pain in arm, tiredness, running nose, sore throat, body aches, headache, congestion, fever, mood swings, extreme fatigue and upset stomach was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pain in extremity, Pyrexia, Rhinorrhoea
Clinical narrative: Pain in arm; tiredness; Headaches; Congestion; Mood swings; Extreme fatigue; Upset stomach; Running nose; Sore throat; Fever; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09May2021 at 11:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, allergy to nuts and nickel. Concomitant medications included zolpidem tartrate (AMBIEN), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and valaciclovir hydrochloride (VALTREX), all for unknown indication and from unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13May2021, the patient experienced pain in arm and quick onset tiredness which lasted for few days. On day 4, the patient experienced running nose, sore throat, fever, body aches and from day 5-7, patient experienced headaches, body aches, congestion, fever, sore throat, mood swings, extreme fatigue, upset stomach. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events pain in arm, tiredness, running nose, sore throat, body aches, headache, congestion, fever, mood swings, extreme fatigue and upset stomach was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass, Lymph node pain, SARS-CoV-2 test
Clinical narrative: Lump on Left Armpit; Lump on Left Armpit that is tender and hurts. Suspect to be Lymphnode; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 13May2021 at 14:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies. Concomitant medications included paracetamol (TYLENOL) for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Apr2021 at 15:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. On 14May2021 at 10:15, the patient experienced a lump on the left armpit that was tender and hurt and was suspected to be a lymph node. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. The patient had been tested for COVID post-vaccination. On an unknown date in May2021, the patient underwent nasal swab test named MAP test and the result was pending. The clinical outcome of the events lump on the left armpit and armpit was tender were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Computerised tomogram thorax, Cough, Electrocardiogram
Clinical narrative: Had to cough/this dry, unproductive cough has continued; A small amount of fluid in my left lung; This is a spontaneous report from a contactable consumer (patient). This 59-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 12Apr2021 at 17:30 (at the age of 59-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included high cholesterol and acid reflux. The patient had not been sick with an illness over the last year and a half (as of 16May2021). The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications included rosuvastatin (CRESTOR; 5 mg) and omeprazole (PRILOSEC) from unknown dates for unknown indications. The patient did not have any known allergies. The patient previously received dose 1 of BNT162B2 on 22Mar2021 at 17:30 as a single dose in the left arm for COVID-19 immunization. On 13Apr2021 at 07:30 the patient experienced a dry, unproductive cough. The event was reported as non-serious. The patient was not hospitalized for the event. The patient visited an ear, nose, throat (ENT) doctor and primary/cardiologist doctor as a result of the event. The morning after the second vaccine (13Apr2021) the patient woke up and immediately upon taking a deep breath had to cough. This sensation continued for approximately half the day after which she could take a deep breath without coughing but she continued to intermittently have the sensation to cough. This dry, unproductive cough continued for the last 4 and a half weeks (as of 16May2021). Other than the cough she had no other symptoms that would indicate illness. The patient underwent lab tests and procedures which included  nasal scope by her ENT doctor on an unknown date with unknown results, blood work on an unknown date with unknown results, EKG on an unknown date with unknown results, chest X-ray on an unknown date with results of small amount of fluid in her left lung, and chest CT on an unknown date which was clear. The ENT and cardiologist felt this was some sort of reaction to the vaccine. The patient did not receive any treatment for the events. The outcomes of dry, unproductive cough, and fluid in her left lung were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Nasoendoscopy, Pulmonary oedema
Clinical narrative: Had to cough/this dry, unproductive cough has continued; A small amount of fluid in my left lung; This is a spontaneous report from a contactable consumer (patient). This 59-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 12Apr2021 at 17:30 (at the age of 59-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included high cholesterol and acid reflux. The patient had not been sick with an illness over the last year and a half (as of 16May2021). The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications included rosuvastatin (CRESTOR; 5 mg) and omeprazole (PRILOSEC) from unknown dates for unknown indications. The patient did not have any known allergies. The patient previously received dose 1 of BNT162B2 on 22Mar2021 at 17:30 as a single dose in the left arm for COVID-19 immunization. On 13Apr2021 at 07:30 the patient experienced a dry, unproductive cough. The event was reported as non-serious. The patient was not hospitalized for the event. The patient visited an ear, nose, throat (ENT) doctor and primary/cardiologist doctor as a result of the event. The morning after the second vaccine (13Apr2021) the patient woke up and immediately upon taking a deep breath had to cough. This sensation continued for approximately half the day after which she could take a deep breath without coughing but she continued to intermittently have the sensation to cough. This dry, unproductive cough continued for the last 4 and a half weeks (as of 16May2021). Other than the cough she had no other symptoms that would indicate illness. The patient underwent lab tests and procedures which included  nasal scope by her ENT doctor on an unknown date with unknown results, blood work on an unknown date with unknown results, EKG on an unknown date with unknown results, chest X-ray on an unknown date with results of small amount of fluid in her left lung, and chest CT on an unknown date which was clear. The ENT and cardiologist felt this was some sort of reaction to the vaccine. The patient did not receive any treatment for the events. The outcomes of dry, unproductive cough, and fluid in her left lung were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.